Latest Breaking News On - Essam farouk - Page 1 : comparemela.com
EBRD, DPI and BII announce exit from KELIX bio
ebrd.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ebrd.com Daily Mail and Mail on Sunday newspapers.
Mubadala Acquires KELIX bio, Expanding Access to Life-Saving Pharmaceuticals in Emerging Markets
news.europawire.eu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news.europawire.eu Daily Mail and Mail on Sunday newspapers.
The transaction is set to be one of the largest private equity exits and M&A deals in the pharmaceutical sector in Africa over the last twenty years· DPI, BII and EBRD, founding investors of KELIX bio, have entered a binding agreement to fully exit their inv.
Julphar acquires full control of Planet Pharmacies
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Net sales for 2020 were Dh581.2 million, which is a 93 per cent gain on 2019’s Dh301.5 million. Dr. Essam Farouk, CEO of Julphar, said in a statement: “We will consolidate our market position and expand our market share in the MENA region. The ongoing transformation programme will make the company more competitive in our core markets.
“Last year, the capital restructuring marked a major milestone in our transformation. We are confident that the company is well on track to regain its leading market position in the MENA region.”
Capital plans Last year, Julphar’s board approved a special resolution for a capital reduction followed by a capital increase through a rights issue.